KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Depreciation & Amortization (CF) (2016 - 2025)

Tenet Healthcare's Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $231.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 19.69% year-over-year to $231.0 million; the TTM value through Dec 2025 reached $863.0 million, up 5.5%, while the annual FY2025 figure was $863.0 million, 5.5% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $231.0 million at Tenet Healthcare, up from $218.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $231.0 million in Q4 2025 and bottomed at $193.0 million in Q4 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $211.0 million (2021), against an average of $212.4 million.
  • The largest annual shift saw Depreciation & Amortization (CF) fell 13.73% in 2021 before it grew 19.69% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $201.0 million in 2021, then grew by 5.97% to $213.0 million in 2022, then grew by 1.41% to $216.0 million in 2023, then fell by 10.65% to $193.0 million in 2024, then grew by 19.69% to $231.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Depreciation & Amortization (CF) are $231.0 million (Q4 2025), $218.0 million (Q3 2025), and $208.0 million (Q2 2025).